Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 53,591 | 68,743 | 56,062 | 78,030 | 41,853 |
| Cost of Goods | 3,292 | 2,572 | 3,045 | 2,198 | 1,582 |
| Gross Profit | 50,299 | 66,171 | 53,017 | 75,832 | 40,271 |
| Operating Expenses | 98,821 | 72,317 | 69,805 | 70,578 | 71,745 |
| Operating Income | -48,230 | -5,574 | -16,743 | 5,452 | -30,892 |
| Interest Expense | 3,118 | 2,884 | 3,303 | 3,446 | 3,421 |
| Other Income | 734 | -673 | 1,004 | 93 | 766 |
| Pre-tax Income | -50,614 | -9,131 | -19,042 | 2,099 | -33,547 |
| Income Tax | 355 | 389 | 221 | 829 | 191 |
| Net Income Continuous | -50,969 | -9,520 | -19,263 | 1,270 | -33,738 |
| Net Income | $-50,969 | $-9,520 | $-19,263 | $1,270 | $-33,738 |
| EPS Basic Total Ops | -1.06 | -0.21 | -0.46 | 0.09 | -0.82 |
| EPS Basic Continuous Ops | -1.06 | -0.21 | -0.46 | 0.09 | -0.82 |
| EPS Diluted Total Ops | -1.06 | -0.21 | -0.46 | 0.09 | -0.82 |
| EPS Diluted Continuous Ops | -1.06 | -0.21 | -0.46 | 0.09 | -0.82 |
| EBITDA(a) | $-41,147 | $643 | $-10,691 | $11,558 | $-20,346 |